Prof. Sei Kwang Hahn's

Biomedical Nanomaterials Lab

About Lab

Wearable Devices

Nanomedicines

Smart Healthcare

  • About Lab






     


     

    Biomedical Nanomaterials Lab (BNL) is Prof. Sei Kwang Hahn’s laboratory in the Department of Materials Science and Engineering (DMSE) at the world class research university, POSTECH. BNL is working for smart biomaterials to develop nanomedicines including biosensors, bio-imaging systems, drug delivery systems, regenerative medicines and healthcare wearable devices.

    Prof. Hahn published more than 130 journal papers including Nature Reviews Materials, Nature Photonics, Nature Communications, Science Advances, Progress in Polymer Science, Advanced Materials, and ACS Nano, and filed more than 120 Korean and international patents. He is one of the Editorial Board Members for Biomacromolecules (American Chemical Society), ACS Biomaterials Science and Engineering, and Applied Sciences, and the Associate Editor of  Biomaterials Research. He won the Korean President Award in 2015, the Minister of Health & Welfare Award in 2017, and the Korean Minister of Education Award in 2013. He was a visiting professor at the Harvard Medical School in 2012. He is a member of National Science and Technology Council.

    BNL has greatly contributed to the successful commercialization of SR-hGH (Declage) in collaboration with LG Lifesciences, artificial bone graft (BonePlus) with MegaGen, post-surgical adhesion prevention solution (Medicurtain) with ShinPoong Pharmaceuticals and EGF cosmedicals (PHI-EGF) with PHI BioMed. Recently, BNL has developed smart contact lenses for ubiquitous healthcare supported by the Samsung Futuristic Technology Foundation. Prof. Hahn worked as a consultant for Johnson & Johnson in New Jersey and made a collaboration contract with Hoffman-La Roche. He is the CEO of a bio-venture company of “PHI BioMed” founded in 2014 and the Outside Director of KISWIRE. He was a member of Samsung Future Technology Committee and  the National Science and Technology Council, and is a member of National Academy of Engineering Korea.

  • Professor


     

    Professor : Sei Kwang Hahn, Ph.D.
    Contact Information
    아이콘1Office BOIC 1001
    아이콘2Tel 82-54-279-2159
    아이콘3Mobile 82-10-6404-2159
    아이콘4Fax 82-54-279-2399
    아이콘5E-mail skhanb@postech.ac.kr
    Affiliation
    • - Department of Materials Science & Engineering, POSTECH
    • - School of Interdisciplinary Bioscience and Bioengineering
    • - POSTECH Biotech Center
    Education
    • 2001.4 ~ 2002.5   Dept. of Bioengineering, University of Washington (Post-doc)
    • 1993.3 ~ 1996.8   Dept. of Chemical and Biomolecular Engineering, KAIST (Ph.D.)
    • 1991.3 ~ 1993.2   Dept. of Chemical and Biomolecular Engineering, KAIST (M.S.)
    • 1987.3 ~ 1991.2   Dept. of Chemical and Biomolecular Engineering, KAIST (B.S.)
    • 1985.3 ~ 1987.2   GyeongNam Science High School
    Professional Experience
    • 2019.6 ~ Present Seok Cheon Chair Professor in the Department of Materials Science and Engineering at POSTECH
    • 2019.2 ~ 2020.1   Visiting Professor at Stanford University (Zhenan Bao Group)
    • 2012.1 ~ 2014.1   Visiting Associate Professor at Harvard Medical School and Massachusetts General Hospital
    • 2009.3 ~ 2013.2   Associate Professor in the Department of Materials Science and Enginnering at POSTECH
    • 2005.7 ~ 2009.2   Assistant Professor in the Department of Materials Science and Enginnering at POSTECH
    • 2002.6 ~ 2005.7   Stage II Research Scientist in the Research Institute of Chugai Pharm. Co., Roche Group
    • 2001.4 ~ 2002.5   Postdoctoral Fellow in the Department of Bioengineering at the University of Washington
    • 1996.7 ~ 2001.3   Senior Research Scientist in the Life Science Research Institute of LG Chemical Ltd.
    • 1993.3 ~ 1996.8   Teaching and Research Assistant in the Department of Chemical Engineering at the KAIST
    • 1994.7 ~ 1994.9   Junior Research Specialist at the University of California, Irvine
    Professional Affiliation
    • - Materials Research Society
    • - Society for Biomaterials
    • - Controlled Release Society
    • - American Association of Pharmaceutical Scientists
    • - Polymer Society of Korea
    • - Korean Society for Biomaterials
    • - Korean Society of Biotechnology and Bioengineering
    Biography
    • Sei Kwang Hahn is the Seok Cheon Endowed Chair Professor in the Department of Materials Science and Engineering, and an adjunct professor in the School of Interdisciplinary Bioscience and Bioengineering at Pohang University of Science and Technology (POSTECH). He obtained his B.S. (1991), M.S. (1993) and Ph.D. (1996) in the Department of Chemical and Biomolecular Engineering at Korea Advanced Institute of Science and Technology (KAIST). As the youngest Ph.D. at LG Chemical Group in 1996, he started his research for the commercial development of the sustained release formulation of hGH under the trade name of Declage?. After that, he did his post-doctoral research with Prof. Allan Hoffman in the Department of Bioengineering at the University of Washington for 2001-2002. He worked at the Hoffman-La Roche group, Chugai Pharmaceutical Co. in Japan for 2002-2005. After joining at POSTECH in 2005, he worked as a consultant for Johnson & Johnson in New Jersey in 2008, an associate visiting professor at Harvard Medical School and Massachusetts General Hospital for 2012-2013, and a visiting professor at Stanford University for 2019-2020. He is the founder and CEO of PHI BIOMED Co., one of the National Innovative Enterprise 1000 nominated by the Korean Minister of SMEs and Startups. He won the Best National Convergence Technology Award in 2023, the prestigious Medical Industry Grand Prize and Song-Gok Science & Technology Award in 2022, the Controlled Release Society Award in 2018, the Minister of Health and Welfare Award in 2017, and the Korean President Award in 2015. He was the Samsung Future Technology Committee for 2016-2018 and the Presidential Advisory Council on Science and Technology for 2017-2019. He was nominated as the National Academy of Engineering of Korea in 2020, the Outside Director of Kiswire Co. in 2020, the Fellow of Biomaterials Science and Engineering for the International Union of Societies for Biomaterials Science and Engineering (IUSBSE) in 2023, and the Vice President for the Polymer Society of Korea in 2024. He published more than 180 journal papers including Nature Reviews Materials, Nature Photonics, Nature Communications, Science Advances, Progress in Polymer Science, and Advanced Materials, and filed more than 150 Korean and international patents. He has worked as the Editorial Board Member of Advanced Drug Delivery Reviews, ACS Biomaterials Science and Engineering, ACS Applied Bio Materials, Biomacromolecules and Advanced Nanobiomed Research, the Guest Editor of Advanced Drug Delivery Reviews, Biomaterials, Journal of Controlled Release and APL Materials, and the Associate Editor of Biomaterials Research (IF 11.3) and Biomaterials (IF 14.0).
  • Research
    Research Topics - Biomaterials for Nanomedicine

    The convergence of recent advances in nanotechnology with modern biology and medicine has created the new research domain of nanobiotechnology. The use of nanobiotechnology in medicine is termed nanomedicine. Nanomedicine research includes targeted cancer therapies, localized drug delivery, improved cell material interactions, the development of diagnostics for rapid monitoring, scaffolds for tissue engineering, and gene delivery systems. Successful research and development in nanomedicine where ultimately patients can benefit from these new technologies require the interaction of a multitude of disciplines including material science and engineering, cellular biology and clinical translational research.
    Biomaterials research topics for nano-medicine at BNL
    Biosensor
    Smart Contact Lens for Theranosis

    Biosensor

    Bio-Imaging
    Intravital Multi-photon Microscopy

    Bio-Imaging

    Drug Delivery
    Drug Conjugate and Depot System

    Drug Delivery

    Tissue Engineering
    Hydrogel for Regenerative Medicine

    Tissue Engineering

TOP